Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Millions of Americans depend on home health care services to recover from surgeries and hospital stays, as well as to manage daily life with chronic conditions.

4 Jun 2014

Culture-based tests can help in accurate diagnosis of sore throats

Clinical guidelines conflict on testing teens and adults whose symptoms point to a possible strep throat.

29 May 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

Researchers identify small molecule that prevents bacteria from forming into infectious biofilms

Researchers at the University of British Columbia have identified a small molecule that prevents bacteria from forming into biofilms, a frequent cause of infections.

23 May 2014

MGH researchers test novel approach to disinfecting wounds in animal study

Application of a technology currently used to disinfect food products may help to get around one of the most challenging problems in medicine today, the proliferation of bacteria resistant to antibiotics and other antimicrobial drugs.

22 May 2014

Soil bacteria have strategies for fighting antibiotics

Drug-resistant bacteria annually sicken 2 million Americans and kill at least 23,000. A driving force behind this growing public health threat is the ability of bacteria to share genes that provide antibiotic resistance.

22 May 2014

A novel strategy to uncover new antibiotics

Resistance to antibiotics has been steadily rising, posing a threat to public health. Now, a method from Mohammad Seyedsayamdost, an assistant professor of chemistry at Princeton University, may open the door to the discovery of a host of potential drug candidates.

21 May 2014

Combination of metformin and rapamycin shows potential in treating aging and related diseases

A proven approach to slow the aging process is dietary restriction, but new research in the Linus Pauling Institute at Oregon State University helps explain the action of a drug that appears to mimic that process - rapamycin.

21 May 2014

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Aradigm Corporation (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead inhaled antibiotic candidate, Pulmaquin®, as a Qualified Infectious Disease Product (QIDP).

20 May 2014

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Sanofi Pasteur, the vaccines division of Sanofi, presented Phase II (H-030-012) trial results for an investigational vaccine for the prevention of Clostridium difficile infection at the 114th General Meeting of the American Society for Microbiology.

20 May 2014

LA BioMed researcher receives APIC Award for Publication Excellence

Loren Miller, MD, a Los Angeles Biomedical Research Institute (LA BioMed) lead researcher, is the senior author of a published study that will receive the Association for Professionals in Infection Control and Epidemiology (APIC) Award for Publication Excellence at its annual conference in Anaheim on June 7.

20 May 2014

New toolkit to help prevent and control healthcare-associated infections

Montefiore Medical Center, in partnership with Boston University School of Public Health, today announced the launch of a toolkit to help prevent and control the emergence of a dangerous and highly contagious infection in healthcare settings.

19 May 2014

Painkillers may prevent repeated urinary tract infections in women, says study

Women plagued by repeated urinary tract infections may be able to prevent the infections with help from over-the-counter painkillers, new research in mice shows.

19 May 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Specific Technologies, developer of the SpecID™ system to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced that for the first time it will showcase its transformative SpecID blood culture system at the 114th General Meeting of the American Society for Microbiology, May 17-20, 2014 in Boston, Massachusetts at the Boston Convention and Exhibition Center.

16 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today announced it has completed enrollment of patients in its global Phase 2b viral conjunctivitis trial, BAYnovation.

16 May 2014

Link found between antibiotic use in babies and asthma

New research has shed light on how treating babies with antibiotics may lead to an increased risk for asthma.

15 May 2014

C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children’s Center and Harvard Medical School.

13 May 2014

Viewpoints: heath insurance and mortality; newly insured vs. previously insured on marketplaces

The connection between health insurance and mortality is really hard to pin down, even if insurance truly has strong protective effects. The uninsured in America are mainly non-elderly adults.

13 May 2014

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the side effects of antibiotics and the occurrence of severe Clostridium difficile infections.

13 May 2014

Antibiotic News and Research

Further Reading

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Culture-based tests can help in accurate diagnosis of sore throats

Growing resistance to antibiotics demands a coordinated global response, say experts

Researchers identify small molecule that prevents bacteria from forming into infectious biofilms

MGH researchers test novel approach to disinfecting wounds in animal study

Soil bacteria have strategies for fighting antibiotics

A novel strategy to uncover new antibiotics

Combination of metformin and rapamycin shows potential in treating aging and related diseases

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

LA BioMed researcher receives APIC Award for Publication Excellence

New toolkit to help prevent and control healthcare-associated infections

Painkillers may prevent repeated urinary tract infections in women, says study

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

Link found between antibiotic use in babies and asthma

C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

Viewpoints: heath insurance and mortality; newly insured vs. previously insured on marketplaces

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News